Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
SCHOLAR ROCK HOLDING CORPORATION (SRRK), most recent 12 months reported: net loss $408.59M, free cash flow -$297.01M. Latest balance sheet on file: liquid cash $492.09M, total debt $196.2M, net cash $295.88M. From SEC filings. More on SCHOLAR ROCK HOLDING CORPORATION: Revenue · Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): SAB BIOTHERAPEUTICS, INC. · Sana Biotechnology, Inc. · Solid Biosciences Inc. · SILEXION THERAPEUTICS CORP · Protara Therapeutics, Inc. · TECTONIC THERAPEUTIC, INC. · Instil Bio, Inc. · Tenaya Therapeutics, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.